Aging is a disease that can be cured.
And we know how to do it.
Epigenetic dysregulation acts as a conductor in the cellular aging process. It controls which genes are turned on or silenced, which directly influences how we age. The exciting thing is that with our technology we can intervene in epigenetic mechanisms to restore cellular youthfulness and potentially reverse the signs of aging in a multi-organ and systemic way.
Introducing ICER
The future of anti-aging therapies.
ICER, driven by partial cellular reprogramming, leads the field of anti-aging therapies with exceptionally high in vivo expression rates, being able to access prior "cellular backup" in multiple organs, thus reversing the effects of aging on the body. This breakthrough promises a very near future in which aging is reversible, providing an exponential increase in maximum life expectancy in humans.
“Our technology, by overcoming the bottleneck of reprogramming therapies, emerges as the key missing piece in the fight against aging, marking a before and after on the road to prolonging life and human well-being.”
"In the landscape of aging research, our technology represents a revolution, opening new frontiers in the intervention of the human aging process, and pointing to a future where longevity and vitality merge in harmony with innovation."
The Team
Marcos Arrut
CEO
Marcos Arrut is an aging researcher with half a decade of experience in this field. He is currently studying Biotechnology and Molecular Biology. Marcos has been recognized for his contributions in the field of anti-aging treatments. His work enriches our research and strengthens our commitment to science.
Francisco Vargas
COO
Francisco Javier Tejero Vargas, a pharmacist with a solid academic background and an MBA, combines science with business acumen. He has extensive experience in clinical trials and aging studies, allowing him to effectively address the challenges of science through research and product development.
Their versatility and leadership in scientific and commercial understanding drive innovative therapies such as ours.
Julia Vall
Scientific Advisor
Julia, a graduate in Molecular Biology and Biochemistry, plays an essential role in the development of the technical and scientific part of ICER. Her expertise ensures scientific integrity and technical rigor in all phases of the project. Moreover, her experience ensures that the most complex and fundamental aspects of ICER's research are addressed with precision and efficiency.
Nicolas Fuentes
Scientific Advisor
Nicolas Fuentes is a key biomedical engineer on our team, as he effectively merges medicine and biology. His expertise in neuroscience has been instrumental in developing ICER so that it can cross the blood-brain barrier. His expertise propels our technology to new horizons at the intersection of science and health.
Interested in learning more?
Feel free to ask any questions about ICER that you may have.